Published in J Virol on March 01, 1991
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Three-dimensional structure of Theiler murine encephalomyelitis virus (BeAn strain). Proc Natl Acad Sci U S A (1992) 1.50
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol (1997) 1.20
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Predominant binding of Theiler's viruses to a 34-kilodalton receptor protein on susceptible cell lines. J Virol (1991) 1.11
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
Chimeric cDNA studies of Theiler's murine encephalomyelitis virus neurovirulence. J Virol (1993) 1.01
Assembly of Theiler's virus recombinants used in mapping determinants of neurovirulence. J Virol (1993) 0.94
The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol (1995) 0.92
Chimeric Theiler's virus with altered tropism for the central nervous system. J Virol (1994) 0.91
Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J Virol (1996) 0.89
A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J Virol (1998) 0.83
Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination. Infect Immun (1975) 7.12
Analysis of the complete nucleotide sequence of the picornavirus Theiler's murine encephalomyelitis virus indicates that it is closely related to cardioviruses. J Virol (1987) 3.77
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size. J Gen Virol (1980) 3.04
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog (1987) 2.56
Demyelinative myelopathy in mice induced by the DA virus. J Neurol Sci (1976) 2.20
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J Virol (1990) 1.82
Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol (1989) 1.62
Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb Pathog (1989) 1.62
Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J Virol (1989) 1.59
Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus. J Virol (1986) 1.55
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response. J Infect Dis (1978) 1.46
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
Detection of viral sequences of low reiteration frequency by in situ hybridization. Proc Natl Acad Sci U S A (1978) 7.95
Simultaneous in situ detection of viral RNA and antigens. Proc Natl Acad Sci U S A (1984) 2.73
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb Pathog (1987) 2.56
Visna DNA synthesis and the tempo of infection in vitro. Virology (1982) 2.47
Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J Exp Med (1995) 2.19
Detection of two viral genomes in single cells by double-label hybridization in situ and color microradioautography. Science (1985) 2.09
Theiler's virus infection of beta 2-microglobulin-deficient mice. J Virol (1993) 2.04
Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology (1985) 2.04
Gene expression in visna virus infection in sheep. Nature (1981) 1.98
Demyelinating lesions due to Theiler's virus are associated with ongoing central nervous system infection. J Virol (1986) 1.95
Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). J Immunol (1975) 1.82
Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J Virol (1990) 1.82
The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system. J Virol (1992) 1.76
Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology (1995) 1.72
Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology (1997) 1.70
Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts. Microb Pathog (1989) 1.62
Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet (1993) 1.61
Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J Virol (1989) 1.59
Theiler's virus genome is closely related to that of encephalomyocarditis virus, the prototype cardiovirus. J Virol (1986) 1.55
Role of macrophages during Theiler's virus infection. J Virol (1997) 1.52
Visna virus DNA: discovery of a novel gapped structure. Virology (1981) 1.51
Visna virus RNA synthesis. J Virol (1977) 1.48
FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus. J Virol (1994) 1.48
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Biphasic energy selection for transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart (2007) 1.42
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Subacute pulmonary toxicity from amiodarone. N Y State J Med (1991) 1.39
Theiler's virus and Mengo virus induce cross-reactive cytotoxic T lymphocytes restricted to the same immunodominant VP2 epitope in C57BL/6 mice. J Virol (1997) 1.36
Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J Natl Cancer Inst (1980) 1.36
Minus-strand RNA synthesis in the spinal cords of mice persistently infected with Theiler's virus. J Virol (1988) 1.30
Theiler's virus replication in brain macrophages cultured in vitro. J Virol (1992) 1.30
The infection of mouse by Theiler's virus: from genetics to immunology. Immunol Rev (1997) 1.27
Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography. J Biol Chem (1982) 1.25
Enzymatic reduction of chromate: comparative studies using sulfate-reducing bacteria. Key role of polyheme cytochromes c and hydrogenases. Appl Microbiol Biotechnol (2001) 1.23
Theiler's virus infection induces a specific cytotoxic T lymphocyte response. Cell Immunol (1991) 1.22
The infection caused by visna virus. A model for the study of slow degenerative diseases of the central nervous system. Pathol Biol (Paris) (1977) 1.21
Theiler's virus infection of perforin-deficient mice. J Virol (1998) 1.19
Complexity and polyadenylic acid content of visna virus 60-70S RNA. J Virol (1977) 1.13
Role of the humoral immune response in resistance to Theiler's virus infection. J Virol (1991) 1.11
An early, abundant cytotoxic T-lymphocyte response against Theiler's virus is critical for preventing viral persistence. J Virol (1997) 1.09
Two loci, Tmevp2 and Tmevp3, located on the telomeric region of chromosome 10, control the persistence of Theiler's virus in the central nervous system of mice. Genetics (1999) 1.08
Characterization of B lymphocytes present in the demyelinating lesions induced by Theiler's virus. J Immunol (1989) 1.08
Long-lasting insomnia induced by preoptic neuron lesions and its transient reversal by muscimol injection into the posterior hypothalamus in the cat. Neuroscience (1989) 1.08
Prospective evaluation of heart block complicating early Lyme disease. Pacing Clin Electrophysiol (1992) 1.07
Quantitation, with a new assay, of Theiler's virus capsid protein in the central nervous system of mice. J Virol (1986) 1.07
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med (1982) 1.06
PTFE-encapsulated endovascular stent-graft for transjugular intrahepatic portosystemic shunts: experimental evaluation. Radiology (1997) 1.04
Detection of picornavirus sequences in nervous tissue of amyotrophic lateral sclerosis and control patients. Ann Neurol (1985) 1.04
H-2D(b-/-) mice are susceptible to persistent infection by Theiler's virus. J Virol (2000) 1.03
Early infection of the central nervous system by the GDVII and DA strains of Theiler's virus. J Virol (1995) 1.03
Simultaneous in situ detection of two mRNAs in the same cell using riboprobes labeled with biotin and 35S. J Histochem Cytochem (1990) 1.02
In situ analysis of proteolipid protein gene transcripts during persistent Theiler's virus infection. J Histochem Cytochem (1991) 1.01
Interaction of Theiler's virus with intermediate filaments of infected cells. J Virol (1998) 1.01
Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system. J Gen Virol (2001) 0.99
Genetic determinants of the demyelinating disease caused by Theiler's virus. Microb Pathog (1991) 0.99
Escherichia coli is able to produce heterologous tetraheme cytochrome c(3) when the ccm genes are co-expressed. Biochim Biophys Acta (2000) 0.98
Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts. Clin Cancer Res (2000) 0.96
The shiverer mutation affects the persistence of Theiler's virus in the central nervous system. J Virol (1997) 0.96
Molecular mechanism of tumorigenesis in mice transgenic for the human T cell leukemia virus Tax gene. Virology (1998) 0.95
Interleukin 22 is a candidate gene for Tmevp3, a locus controlling Theiler's virus-induced neurological diseases. Genetics (2007) 0.95
[Prognostic value of blood cholesterol in women with cancer of the breast]. Pathol Biol (1967) 0.95
The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons. J Virol (1998) 0.95
Detection of tissue culture-adapted Theiler's virus RNA in spinal cord white matter cells throughout infection. Infect Immun (1982) 0.95
Hydrogen metabolism in the hyperthermophilic bacterium Aquifex aeolicus. Biochem Soc Trans (2005) 0.93
Borna disease virus persistent infection activates mitogen-activated protein kinase and blocks neuronal differentiation of PC12 cells. J Biol Chem (2000) 0.93
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. Am J Cardiol (1993) 0.92
Chimeric Theiler's virus with altered tropism for the central nervous system. J Virol (1994) 0.91
Homology between a 173-kb region from mouse chromosome 10, telomeric to the Ifng locus, and human chromosome 12q15. Genomics (2001) 0.91
T lymphocyte repertoire in Theiler's virus encephalomyelitis: the nonspecific infiltration of the central nervous system of infected SJL/J mice is associated with a selective local T cell expansion. Eur J Immunol (1995) 0.90
Viral load and a locus on chromosome 11 affect the late clinical disease caused by Theiler's virus. J Virol (1999) 0.90
In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab (1995) 0.90
Reversibility of para-chlorophenylalanine-induced insomnia by intrahypothalamic microinjection of L-5-hydroxytryptophan. Neuroscience (1989) 0.90
The high molecular weight RNA of Visna virus. Biochimie (1973) 0.90
The Th1/Th2 balance does not account for the difference of susceptibility of mouse strains to Theiler's virus persistent infection. J Immunol (1999) 0.89
Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J Virol (1996) 0.89
Detection of a low frequency of activated ras genes in human melanomas using a tumorigenicity assay. Cancer Res (1988) 0.89
In vivo administration of interleukin-2 protects susceptible mice from Theiler's virus persistence. J Virol (1997) 0.89
Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo. Mol Cancer Ther (2001) 0.89
The GDVII strain of Theiler's virus spreads via axonal transport. J Virol (1999) 0.88
Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue. Nature (1986) 0.88